Browsing Category

Health

Smith & Nephew Reports Healthy Revival

Smith & Nephew's revival is taking hold, according to the chief executive of the FTSE 100 medical products maker after it posted better-than expected fourth-quarter financial results. The underlying revenue increased by 6.4 percent…

Redx Pharma is aiming for New York listing

Redx Pharma has decided to list in New York because it wants to tap into a wider and more specialized pool of investors. The latest blow for the City is that the London-listed Biotechnology Company, which has been through a turbulent…

Debt-laden Haleon kisses goodbye to ChapStick

Haleon sold ChapStick for more than $500m as it sought to reduce its debts while also boosting its stock price. The FTSE-100 company has agreed that it will sell its lip balms to Suave Brands for approximately $430 million cash plus a…